Clinical Trial Update: A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effectiveness and tolerability of aripiprazole in bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Bipolar Depression | Phase 4 | Status: COMPLETED